MedPath

Serc

Brand Name: Serc

Generic Name: Betahistine Hydrochloride

Active
Registration Number

DRP-473

Dosage Form

Tablet

Issuance Date

February 19, 2024

Expiry Date

April 15, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength16mg
PackagingBlister pack x 25's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-vertigo
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Betahistine HydrochlorideActive
Monograph: Betahistine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform